ASP Isotopes extends merger offer deadline to November 28

Renergen (RGNNF) and ASP Isotopes (ASPI) said they remain fully committed to the merger and are still optimistic that the remaining offer conditions can be met by September 30. The companies added, “However, it is not unusual for the fulfilment of conditions for a transaction of this nature to require additional time when regulatory or 3rd party approvals are required as these are out of the control of both ASPI and Renergen. Key milestone transaction approvals have already been received, including the approval from the Competition Commission which has paved the way for the two companies to plan integration processes and begin collaborating, as detailed in the Renergen SENS released on 14th August 2025.” ASP has extended the deadline for the fulfilment of the outstanding conditions, from September 30 to November 28.